Written by Graham Pechenik and Chris Byrnes MAPS Bulletin 2021: Vol. 31, No. 2 Download this article. As the psychedelics space continues its faster-than-light expansion, controversies have exploded over …
Written by Frank Gerratana, J.D. MAPS Bulletin 2021: Vol. 31, No. 2 Download this article. In the last few months, the topic of patents and psychedelic medicine has turned up several times in the news …
MAPS Bulletin 2021: Vol. 31, No. 2 Download this article. Celebrating 35 Years of MAPS and Introducing Our New Logo This year marks the 35th anniversary of the Multidisciplinary Association for Psychedelic …
Written by Natalie Lyla Ginsberg, M.S.W. and Ismail Lourido Ali, J.D. MAPS Bulletin 2021: Vol. 31, No. 2 Download this article. MAPS’ Values were first introduced over a decade ago. The existential …
Written by Rick Doblin, Ph.D. MAPS Bulletin 2021: Vol. 31, No. 2 Download this article. MAPS has recently completed its first Phase 3 study of MDMA-assisted therapy for PTSD for review and potential approval …
Download this entire issue (Large Size / Reduced Size) or browse individual articles by title below. Front Cover“Psychedelic Healing” by Alex Grey Back Cover“New Order” by Allyson …
Summary: MAPS-sponsored researcher Bruce Poulter, M.P.H., joins the Keep Talking Podcast to discuss his interest in MDMA-assisted therapy, a patient’s experience of receiving such therapy, and MAPS’ …
Summary: MAPS Founder and Executive Director Rick Doblin, Ph.D., sits down with Aubrey Marcus to explain MAPS’ multiple research, policy, and education priorities in the context of our larger, long-term …
MAPS Public Benefit Corporation (MAPS PBC) Chief Executive Officer (CEO) Amy Emerson joins the Wellness Mama Podcast to increase awareness of psychedelic-assisted therapy and provide updates about MAPS-sponsored …
Summary: Berra Yazar-Klosinski, Ph.D., of MAPS and MAPS Public Benefit Corporation (MAPS PBC) joins Northstar Sleep School’s podcast to share progress updates about MAPS’ research and consider …
MAPS is sponsoring a Phase 1, open-label study of MDMA’s effect on hepatic impairment (liver disease). While the study site is prepared, this study has not yet enrolled any participants and enrollment …
During this year’s virtual Burning Man, Zendo Project will be hosting a brief educational presentation and hosting the EntheoGeneration speaker series on September 1 at 11:30 AM PT. After our presentation, …
